NCT01272037 2026-03-18
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
12 trialsNCT02089100 2024-08-15
STEREO-SEIN
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Recruiting
NCT03417622 2021-02-25
Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy
Mansoura University
Phase 3 Recruiting
NCT02532400 2020-03-11
COMPETE
Ruijin Hospital
Phase 3 Terminated
NCT01099436 2020-01-21
NEO-ZOTAC
Borstkanker Onderzoek Groep
Phase 3 Completed
NCT01104571 2018-09-17
EPHOS-B
Institute of Cancer Research, United Kingdom
Phase 3 Unknown
NCT00017095 2013-10-24
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00288002 2013-08-26
Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00070278 2013-08-07
Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00427245 2013-08-07
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002696 2013-08-02
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Suspended
NCT00072020 2013-08-02
Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown